Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 18c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Zimmer Biomet (ZBH) PT Raised to $188 at Truist Securities Following Earnings
May 4, 2021 2:01 PM EDTTruist Securities analyst Kaila Krum raised the price target on Zimmer Biomet (NYSE: ZBH) to $188.00 (from $174.00) while maintaining a Buy rating.
The analyst commented, "Zimmer Biomet reported 1Q21 results with both revenue and adj. EPS above consensus. After focusing on the spinoff last quarter,... More
Zimmer Biomet (ZBH) PT Raised to $202 at Needham & Company Following Earnings
May 4, 2021 2:00 PM EDTNeedham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $202.00 (from $192.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 1Q21 revenue and EPS beat consensus. ZBH's underlying revenue growth improved in 1Q21, which we believe was... More
Wells Fargo Introduces 35 "Signature Picks" - Here's Which Stocks Made It
May 3, 2021 7:17 AM EDTChristopher Harvey, a senior research analyst at Wells Fargo, unveiled today the "Signature Picks" portfolio consisting of 35 stocks.
A portfolio, accessible under the Bloomberg ticker WFSSBEST Index, highlighting the banks "best stock ideas in a diversified, risk-adjusted package." The goal is to outperform the S&P500 over a 1-year period via stock selection, not sector rotation, Harvey writes in a note.
Signature Picks has no preordained style/factor biases (unlike our former model portfolio, the QQP). It is designed to be an eclectic/opportunistic portfolio with a... More
